Nicolas Mourier

Inhibition of Human Immunodeficiency Virus Type 1 Replication by Phosphonoformate- and Phosphonoacetate-2',3'-Dideoxy-3'-thiacytidine Conjugates

Anne‐Sophie Charvet, Michel Camplo, Philippe Faury et al. · Journal of Medicinal Chemistry · 1994 · 28 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Tissue Disposition of 5‐<i>o</i>‐Carboranyluracil—A Novel Agent for the Boron Neutron Capture Therapy of Prostate Cancer

Raymond F. Schinazi, Selwyn J. Hurwitz, Irina Liberman et al. · Nucleosides Nucleotides & Nucleic Acids · 2004 · 17 citations

Medicine, Oncology, Pharmacology +14

Enantioselective synthesis and biological evaluation of 5-o-carboranyl pyrimidine nucleosides

Nicolas Mourier, Alessandra Eleuteri, Selwyn J. Hurwitz et al. · Bioorganic & Medicinal Chemistry · 1999 · 15 citations

Pharmacy, Chemistry, Medicinal Chemistry +14

Synthesis and anti-human immunodeficiency virus type 1 activities of new peptido-nucleoside analogues

Michel Camplo, V. NIDDAM, Philippe Barthélémy et al. · European Journal of Medicinal Chemistry · 1995 · 15 citations

Pharmacy, Medicinal Chemistry, Drug Design +13

Synthesis and antiviral activity of N-4′-dihydropyridinyl and dihydroquinolinylcarbonyl-2-hydroxymethyl-5-[cytosin-1′-yl]-1,3-oxathiolane derivatives against human immunodeficiency virus and duck hepatitis B virus

Michel Camplo, A. S. CHARVET‐FAURY, Christelle Borel et al. · European Journal of Medicinal Chemistry · 1996 · 13 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14